MedTrace Logo

Transcranial Direct Current Stimulation (tDCS) as Treatment Method for Pain in Fibromyalgia

NCT01598181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-02-16

No results posted yet for this study

Summary

The purpose of this study is to investigate Transcranial Direct Current Stimulation as treatment method for pain in fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

DEVICE

tDCS NeuroConn DC-stimulator plus

Anodal tDCS, M1, cathode supraorbital left, 2 mA, 20 min, 5 consecutive days.

DEVICE

sham tDCS

similar montage and time as active. Stimulation fades out after 20 sec.

Sponsors & Collaborators

  • Stiftelsen Helse og Rehabilitering

    collaborator OTHER

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Per Aslaksen, ph.d · University of Tromso

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-06-30
Completion
2013-10-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598181 on ClinicalTrials.gov